Aadi Bioscience, Inc.AADINASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P3
Near historical low
vs 3Y Ago
-5.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -70.61% |
| Q2 2025 | 455.41% |
| Q1 2025 | -38.75% |
| Q4 2024 | 43.51% |
| Q3 2024 | -23.65% |
| Q2 2024 | -3.68% |
| Q1 2024 | 6.46% |
| Q4 2023 | 7.38% |
| Q3 2023 | -10.70% |
| Q2 2023 | 21.53% |
| Q1 2023 | 16.94% |
| Q4 2022 | 6.79% |
| Q3 2022 | 13.55% |
| Q2 2022 | 13.72% |
| Q1 2022 | -5.99% |
| Q4 2021 | 25.60% |
| Q3 2021 | 88.97% |
| Q2 2021 | -16.44% |
| Q1 2021 | -31.56% |
| Q4 2020 | 122.30% |
| Q3 2020 | -48.47% |
| Q2 2020 | 75.95% |
| Q1 2020 | 24.05% |
| Q4 2019 | -25.15% |
| Q3 2019 | 25.63% |
| Q2 2019 | -59.47% |
| Q1 2019 | 6.43% |
| Q4 2018 | 20.76% |
| Q3 2018 | 2.78% |
| Q2 2018 | 4.97% |
| Q1 2018 | 6.57% |
| Q4 2017 | 28.49% |
| Q3 2017 | -7.16% |
| Q2 2017 | 40.50% |
| Q1 2017 | 175.45% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |